We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Market Edge Highlights: Microsoft, Amazon, Micron, Union Pacific and Fastenal
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 28, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
Welcome to Episode #171 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
In this episode, Tracey is going solo to discuss long term investing.
Finding winning stocks over 10, 20 or 30 years seems easy, in hindsight. But buying and holding stocks isn’t easy.
No stock goes straight to the sky forever. All stocks have sell-offs, corrections and even “dead” periods where they do relatively little.
Technology Stocks: The Current Superstars
In the 1990s, investors were buying pharmaceutical and technology stocks, especially Internet start-up companies, to try and beat the market averages.
Post-2009, the stocks of choice appear to be, once again technology names, but with an emphasis on content and social media, as FAANG has dominated the conversation.
The thinking goes, that all you have to do is buy and hold some of these names and you’ll outperform.
But, it turns out, technology isn’t the only game in town.
Microsoft’s Return Over the Last 2 Decades
Microsoft’s (MSFT - Free Report) shares are soaring and recently hit new all-time highs. Over the last 5 years, shares are up 194%.
But recent investors should be cautious about applying the recent stock run to a longer time period.
Microsoft’s own share calculator projects that $3,000 invested on April 1, 1999, during the mania of the dot-com boom when the stock was soaring, is worth just $7,612.65 today, without including dividends. While that’s a return of 154%, which isn’t too shabby, it is well under the recent 5-year return.
Lost Decades
Many of the hot 1990s technology stocks had “lost decades” to start the 2000s. Shares fell during the dot-com bust and didn’t recover until well after the Great Recession.
From Apr 1, 1999 to Apr 1, 2009, Amazon (AMZN - Free Report) shares had a total return of a loss of 6.4%.
Brutal.
And there was no dividend for shareholders to take comfort in either.
Micron (MU - Free Report) is another underperformer for long-term investors. Since 1999, the shares have returned just 42%.
Investors would have done better in the S&P 500 or the NASDAQ indexes during that time.
Look Beyond Technology
There’s a myth that technology stocks are where all the big winners are.
This year, several other stocks, in addition to Microsoft, have been hitting all-time highs but they aren’t getting the same attention.
1. Union Pacific (UNP - Free Report) is a railroad founded in 1862. Its shares are hitting new highs. From Apr 1, 1999 to Feb 1, 2019, the shares returned 1,020% which easily beat Microsoft during this period, which returned 189%.
2. Fastenal (FAST - Free Report) is an industrial supplier of nuts and bolts. It went public just one year after Microsoft, in 1987. It, too, is hitting new highs. Since 1999, its shares are up 955%, also easily outpacing Microsoft.
What else should you know about long-term buy and hold investing?
Tune into this week’s podcast to find out.
[In full disclosure, the author of this article owns shares of AMZN in her personal portfolio.]
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Market Edge Highlights: Microsoft, Amazon, Micron, Union Pacific and Fastenal
For Immediate Release
Chicago, IL – March 28, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
Please use the Soundcloud link from this URL for the PR. Thanks: https://www.zacks.com/stock/news/365747/tech-stocks-the-best-longterm-winners)
Tech Stocks: The Best Long-Term Winners?
Welcome to Episode #171 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
In this episode, Tracey is going solo to discuss long term investing.
Finding winning stocks over 10, 20 or 30 years seems easy, in hindsight. But buying and holding stocks isn’t easy.
No stock goes straight to the sky forever. All stocks have sell-offs, corrections and even “dead” periods where they do relatively little.
Technology Stocks: The Current Superstars
In the 1990s, investors were buying pharmaceutical and technology stocks, especially Internet start-up companies, to try and beat the market averages.
Post-2009, the stocks of choice appear to be, once again technology names, but with an emphasis on content and social media, as FAANG has dominated the conversation.
The thinking goes, that all you have to do is buy and hold some of these names and you’ll outperform.
But, it turns out, technology isn’t the only game in town.
Microsoft’s Return Over the Last 2 Decades
Microsoft’s (MSFT - Free Report) shares are soaring and recently hit new all-time highs. Over the last 5 years, shares are up 194%.
But recent investors should be cautious about applying the recent stock run to a longer time period.
Microsoft’s own share calculator projects that $3,000 invested on April 1, 1999, during the mania of the dot-com boom when the stock was soaring, is worth just $7,612.65 today, without including dividends. While that’s a return of 154%, which isn’t too shabby, it is well under the recent 5-year return.
Lost Decades
Many of the hot 1990s technology stocks had “lost decades” to start the 2000s. Shares fell during the dot-com bust and didn’t recover until well after the Great Recession.
From Apr 1, 1999 to Apr 1, 2009, Amazon (AMZN - Free Report) shares had a total return of a loss of 6.4%.
Brutal.
And there was no dividend for shareholders to take comfort in either.
Micron (MU - Free Report) is another underperformer for long-term investors. Since 1999, the shares have returned just 42%.
Investors would have done better in the S&P 500 or the NASDAQ indexes during that time.
Look Beyond Technology
There’s a myth that technology stocks are where all the big winners are.
This year, several other stocks, in addition to Microsoft, have been hitting all-time highs but they aren’t getting the same attention.
1. Union Pacific (UNP - Free Report) is a railroad founded in 1862. Its shares are hitting new highs. From Apr 1, 1999 to Feb 1, 2019, the shares returned 1,020% which easily beat Microsoft during this period, which returned 189%.
2. Fastenal (FAST - Free Report) is an industrial supplier of nuts and bolts. It went public just one year after Microsoft, in 1987. It, too, is hitting new highs. Since 1999, its shares are up 955%, also easily outpacing Microsoft.
What else should you know about long-term buy and hold investing?
Tune into this week’s podcast to find out.
[In full disclosure, the author of this article owns shares of AMZN in her personal portfolio.]
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.